AB

Andrew Brackin

Partner at Gradient | Seed AI VC | Co-Founder at Vial

San Francisco, California

Invests in

Stages:

  • Min Investment:

    $500,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $4,000,000.00

Education

Work Experience

2024

  • Partner

    2024

    Leading early rounds at Gradient, a seed fund focused on applied AI investments. Lead investments in: Enzo – Leading AI platform for post-acute care Hostie – AI concierge for restaurants Paladin – Autonomous drones for public safety Forge – AI-driven tariffs broker Wayline – 24/7 operator for property managers Vera – Clinical AI for medical providers Support: Heyday Health, Vault, RadAI, Zowie, Tella, and others. Early angel in Campus (FF & GC), Silna (Accel), Brain Co. (Elad Gil), Patlytics (Gradient) and Rivet (XYZ & Susa).

2020 - 2023

  • Co-Founder & COO

    2020 - 2023

    Co-founded Vial to run faster clinical trials with technology. Led go-to-market, raised $100M+ in capital from General Catalyst, Buckley Ventures, Byers Capital and Box Group.

2018 - 2020

  • Founding Team, Head of Growth

    2018 - 2020

    One of the first employees at Newfront (backed by Y Combinator, Founders Fund, and Meritech). A tech-enabled insurance brokerage. Valued at $2.2BN in 2022 merger.

2014 - 2017

  • Growth (Acquired)

    2014 - 2017

    Build the #1 mobile job app in the US Acquired by Monster in 2016

2013 - 2015

  • Fellow

    2013 - 2015

    I was selected as one of 20 fellows for the Thiel Fellowship.